These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7210753)

  • 1. [Hypertension as a clinical syndrome].
    Heuchel G
    Z Gesamte Inn Med; 1980 Oct; 35(20):suppl 119-21. PubMed ID: 7210753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extraarticular diseases and findings in gout].
    Heidelmann G; Thiele P; Schröder HE
    Z Gesamte Inn Med; 1982 Jul; 37(13):410-6. PubMed ID: 7136080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The hypertensive metabolic syndrome].
    Horký K
    Vnitr Lek; 1993 Sep; 39(9):836-43. PubMed ID: 8212636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of metabolic disorders in patients with recurrent urinary calculi].
    Schröder HE; Lohse R; Böhm WD
    Z Urol Nephrol; 1981 Mar; 74(3):235-41. PubMed ID: 7223105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection and clinical course of metabolic multiple vascular risk syndrome].
    de Portugal Alvarez J; del Rivero JP; Sánchez Rodríguez A; Chimpen Ruiz V
    An Med Interna; 1993 Aug; 10(8):369-76. PubMed ID: 8218780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
    Jarmuzewska EA; Ghidoni A
    Minerva Med; 2000; 91(1-2):1-15. PubMed ID: 10858728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and cardiovascular characteristics of hypertension. Familial aspects.
    Neutel JM; Smith DH
    Cardiol Clin; 1995 Nov; 13(4):539-47. PubMed ID: 8565017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of arterial hypertension in the pathogenesis of arteriosclerotic vascular changes].
    Hecht A
    Z Gesamte Inn Med; 1980 Oct; 35(19):suppl 101-3. PubMed ID: 7210748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
    Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
    Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of plasma hormones and lipids in healthy elderly Thais compared to patients with chronic diseases: diabetes mellitus, essential hypertension and coronary heart disease.
    Chearskul S; Charoenlarp K; Thongtang V; Nitiyanant W
    J Med Assoc Thai; 2000 Mar; 83(3):266-77. PubMed ID: 10808681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of aortic root dilatation in patients with essential hypertension: relationship with cardiac and extracardiac target organ damage.
    Cuspidi C; Meani S; Fusi V; Valerio C; Sala C; Zanchetti A
    J Hypertens; 2006 Mar; 24(3):573-80. PubMed ID: 16467661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of metabolic syndrome on hypertension-related target organ damage.
    Mulè G; Nardi E; Cottone S; Cusimano P; Volpe V; Piazza G; Mongiovì R; Mezzatesta G; Andronico G; Cerasola G
    J Intern Med; 2005 Jun; 257(6):503-13. PubMed ID: 15910554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aspects of hypertensive heart in arterial hypertension and insulin-resistant syndrome].
    Didenko VA; Simonov DV
    Klin Med (Mosk); 1999; 77(6):28-33. PubMed ID: 10459216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The metabolic syndrome and hyper-Lp(a)-lipoproteinemia in peripheral obliterative atherosclerosis: 2 case reports].
    Tesić D; Derić M; Ivković-Lazar T; Pantelinac P; Lepsanović L
    Med Pregl; 1996; 49(7-8):313-7. PubMed ID: 8926951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patient education in the metabolic syndrome].
    Krahulec B; Raslová K
    Vnitr Lek; 1995 Feb; 41(2):151-5. PubMed ID: 7725642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors for cerebrovascular stroke in a cohort of hypertensive patients].
    Rocha E; Gouveia-Oliveira A; Cotter A; Laranjeiro A; Sousa A; Mendes F; Teixeira H; Galvão J; Miguel JM
    Rev Port Cardiol; 1997 Jun; 16(6):543-56, 508. PubMed ID: 9303608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
    Collins AJ; Vassalotti JA; Wang C; Li S; Gilbertson DT; Liu J; Foley RN; Chen SC; Arneson TJ
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S71-7. PubMed ID: 19231764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
    Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
    J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.